Ryan Werntz, MD

Werntz explains that, prior to PSA screening, about one-fourth to one-fifth of men presented with metastatic disease as a first complaint. Unfortunately, at this point, the disease may be incurable.

Currently, only about 4% of men are presenting with metastatic disease, and Werntz believes that is due to PSA screening. Werntz also urges physicians to continue to recommend PSA screening so as to not repeat the past.

As for evolution of treatment, Werntz believes it starts with PSA screening and knowing how frequent patients may need it. Werntz mentions that surgical treatment is getting better day by day as well.

Ryan Werntz, MD, urologist, Oregon Health and Science University, discusses the significance of prostate-specific antigen (PSA) screening by primary care physicians.

Videos

Ryan Werntz, MD, urologist, Oregon Health and Science University, discusses the significance of prostate-specific antigen (PSA) screening by primary care physicians.


The Significance of PSA Screening by Primary Care Physicians

Ryan Werntz, MD, urologist, Oregon Health and Science University, discusses a study which examined trends in prostate-specific antigen (PSA) utilization in primary care physicians.

View more from the GU Cancers Special Report

Articles

Ryan Werntz, MD, urologist, Oregon Health and Science University, discusses a study which examined trends in prostate-specific antigen (PSA) utilization in primary care physicians. 

Ryan Werntz, MD | Authors

Articles

The Significance of PSA Screening by Primary Care Physicians

Trends in PSA Utilization in Primary Care Physicians